Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of DS-5565 in Asian Patients With Diabetic Peripheral Neuropathic Pain
KCT0001600Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirogabalin in diabetic polyneuropathy (DPN), sponsored by Daiichi Sankyo Co., Ltd.. Started May 2015; status: completed.
02
Drugs
mirogabalin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on KCT0001600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001600.